FASN-mediated prostate cancer progression was suggested as a clue about the failure of the current androgen deprivation therapy, and the inhibition of FASN-mediated signaling was represented as a new therapeutic approach to suppress prostate cancer progression during the castration-resistant stage of prostate cancer [30]. Here, FASN is linked to prostate carcinoma.